通过抑制MKK7/MAPK10信号轴,HACD3促进NSCLC恶性进展
Xiaoying Wang1, Huijun Liang1, Qindan Du1
1Wuxi School of Medicine, Jiangnan University, No. 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China.
BMC cancer
|August 15, 2025
概括
HACD3通过抑制MAPK信号,独立于其脂肪酸脱水酶活性,促进非小细胞肺癌 (NSCLC) 的进展. 针对HACD3为NSCLC患者提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- HACD3是一种非常长链的脂肪酸脱水酶,与各种癌症进展有关.
- 它在启动和促进肺癌方面的具体作用在很大程度上仍未被探索.
研究的目的:
- 研究HACD3在非小细胞肺癌 (NSCLC) 恶性进展中的作用.
- 阐明HACD3影响NSCLC发育的潜在分子机制.
主要方法:
- 在NSCLC组织,细胞系和公共数据库中评估HACD3表达.
- 在体外和体内评估HACD3调制 (敲击/过度表达) 的功能影响.
- 产生和分析Hacd3淘汰赛小鼠,包括脂肪酸分析和肺癌建模.
- 采用转录组学和共免疫沉 (Co-IP) 来识别相互作用的合作伙伴和途径.
- 使用截断的等离子体和合成,绘制功能域的地图.
主要成果:
- 在NSCLC组织和细胞中,HACD3显著过度表达,与恶性行为相关联.
- 在体外和体内,HACD3过度表达增强了瘤的增殖,迁移和瘤生长.
- 删除HACD3可以减少肺部瘤的形成,独立于脂肪酸代谢的变化.
- HACD3直接与MKK7和MAPK10相互作用,抑制了MAPK路径.
- 特定的C端域 (aa231-259) 被确定为HACD3的前瘤活性至关重要.
结论:
- 通过与MKK7和MAPK10的相互作用抑制MAPK信号传递,HACD3促进NSCLC恶性病变.
- 这种亲瘤功能独立于HACD3的正规脱水酶活性.
- 准HACD3,特别是其C端域 (aa231-259),为NSCLC提供了一个新的治疗策略.
相关概念视频
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K


